SCHMID Group Lowers 2026 EBITDA Margin Guidance to 6-9% Despite Strong Order Momentum
SHMD has more than doubled off its 52-week low of $2.
Summary
H1 2026 revenue reached €46.0M with a net loss of €-47.8M, full-year Adjusted EBITDA margin guidance was lowered to 6-9%, order intake accelerated to €96.6M year-to-date, and potential dilution of 13-20% from outstanding financing instruments was disclosed.
Key Events · Earnings and Guidance · SHMD
-
H1 2026 Results: Revenue Up, Net Loss Widens
Revenue reached €46.0M (Q1: €18.2M; Q2: €27.7M) versus €16.9M in H1 2025, but the net loss widened to €-47.8M from €-10.2M, driven by non-cash charges from the XJ Harbour liability conversion and warrant fair-value movements.
-
Full-Year EBITDA Margin Guidance Cut
Adjusted EBITDA margin guidance was lowered to 6-9% from more than 12%, reflecting weaker H1 results and a product mix shift toward lower-margin China business; revenue guidance of more than €100M was confirmed.
-
Order Intake Accelerates to €96.6M
Order intake reached €96.6M year-to-date as of August 21, 2026, with €52.3M in Q3 alone; order backlog stood at €95.0M, and the company now expects to be in the upper half of its €125-150M order intake guidance.
-
Potential Dilution of 13-20%
At illustrative share prices of $5.00-$12.00, outstanding convertible notes, warrants, and options could add 9.3M to 14.9M new shares, representing 13-20% dilution from the current 60,958,903 shares outstanding.
Analysis · SHMD · Technology
H1 2026 revenue jumped to €46.0 million from €16.9 million a year earlier, yet the net loss widened to €-47.8 million, largely due to non-cash charges from the XJ Harbour debt-to-equity conversion and warrant fair-value movements. The company cut its full-year Adjusted EBITDA margin guidance to 6-9% from more than 12%, citing weaker-than-expected first-half results and a product mix shift toward lower-margin China business. Order intake, however, has accelerated dramatically—€96.6 million year-to-date through August 21, with €52.3 million in Q3 alone—and the company now expects to land in the upper half of its €125-150 million order intake guidance. The filing also details potential dilution of 13-20% from outstanding convertible notes, warrants, and options at illustrative share prices of $5.00-$12.00, with the current share price of $4.88 sitting below the $5.00 floor of the dilution table.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 37.4% of the 3413 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SHMD was trading at $4.88 on NASDAQ in the Technology sector, with a market capitalization of approximately $345.8M. The 52-week trading range was $2.00 to $10.65. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.